84 results
424B5
TCRX
Tscan Therapeutics Inc
17 Apr 24
Prospectus supplement for primary offering
9:58pm
were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties … U.S. Treasury securities with insignificant rates of return, or may hold such proceeds as cash, until they are used for their stated purpose. We have
8-K
EX-4.1
TCRX
Tscan Therapeutics Inc
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
. For clarity, the purpose of the foregoing is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage.
(c … for that purpose (the “Warrant Register”), in the name of the record Holder (which shall include the initial Holder or, as the case may be, any assignee
8-K
EX-1.1
x30dj8yy4
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
424B5
d97qtk5
16 Apr 24
Prospectus supplement for primary offering
5:21pm
S-8
vd3ugj7mtz2
6 Mar 24
Registration of securities for employees
4:05pm
S-8
iq0am8mn4jmgiwfy
16 Jun 23
Registration of securities for employees
4:38pm
8-K
EX-1.1
hvvgzisct7w
31 May 23
TScan Therapeutics Announces Launch of Proposed Public Offering
8:16am
8-K
EX-4.1
vapgauqen
31 May 23
TScan Therapeutics Announces Launch of Proposed Public Offering
8:16am